Category Archives: Cancer

Immunotherapy: the next frontier in rational anti-cancer drugs?

The recent approvals of chimeric antigen receptor t-cell (CART) therapy for commercial use has triggered renewed interest in both the immune-biology and molecular details of how cancers evade the immune system, but also generally the utility of “Synthetic Cell Biology” … Continue reading

Posted in Cancer, Synthetic biology | Leave a comment